Trial: 202001160

A Phase 1, Multicenter, Open-label, Dose-Exploration and Dose-Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 650 in Subjects With Advanced Solid Tumors

Phase

I (Cancer Control)

Principal Investigator

Govindan, Ramaswamy

Disease Site

Breast; Corpus Uteri; Ovary

Learn more about this study at: clinicaltrials.gov